75F40123SSN116206.pdf
PDF 143 KB Posted
- Solicitation number
- 75F40123SSN116206
About this file
This Sources Sought Notice seeks preventative maintenance and unlimited repair services for a Leica SP8 STED confocal microscope system located at the FDA's Center for Biologics Evaluation and Research in Silver Spring, Maryland. The services include one planned preventive maintenance visit per year including labor, travel, and replacement parts to maintain operational capability. Responses are requested from small businesses by March 13, 2023 to provide the services for a base year plus four option years from April 15, 2023 through April 14, 2028. Responses should demonstrate relevant past performance and detail technical capabilities to meet the minimum requirements including response times and priority service levels. Pricing for informational purposes would also be provided.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
THIS IS A SOURCES SOUGHT ANNOUNCEMENT, A MARKET SURVEY FOR
WRITTEN INFORMATION ONLY. THIS IS NOT A SOLICITATION
ANNOUNCEMENT FOR PROPOSALS AND NO CONTRACT WILL BE AWARDED
FROM THIS ANNOUNCEMENT. NO REIMBURSEMENT WILL BE MADE FOR ANY
COSTS ASSOCIATED WITH PROVIDING INFORMATION IN RESPONSE TO THIS
ANNOUNCEMENT OR ANY FOLLOW-UP INFORMATION REQUESTS. NO
TELEPHONE CALLS WILL BE ACCEPTED REQUESTING AN RFQ PACKAGE OR
SOLICITATION. THERE IS NO RFQ PACKAGE OR SOLICITATION. IN ORDER TO
PROTECT THE PROCUREMENT INTEGRITY OF ANY FUTURE PROCUREMENT,
IF ANY, THAT MAY ARISE FROM THIS ANNOUNCEMENT, INFORMATION
REGARDING THE TECHNICAL POINT OF CONTACT WILL NOT BE GIVEN AND
NO APPOINTMENTS FOR PRESENTATIONS WILL BE MADE.
The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS) issues this Sources Sought announcement on behalf of the Center for Biologics Evaluation and Research (CBER), Office of Blood Research and Review (OBRR) in order to determine if there are existing small business sources capable providing a Preventative Maintenance (PM) and unlimited repair service contract on a Leica SP8 Stimulated Emission Depletion (STED), Single Molecule Detection Platform (SMD) 2016, Digital LightSheet (DLS) 2017 Confocal Laser Scanning Microscope System, S/N: 8100000223. The Leica SP8 STED confocal microscope system is heavily used at White Oak FDA campus as a scientific tool in CBER’s research programs to support CBER and CDER investigators. To minimize system downtime, the CORE facility requires a “Premium care” or equal service plan for maintenance and unlimited repairs. The instrument was under a maintenance contract which just expired February 25, 2023. A new contract is required as soon as possible.
If your firm is considered a small business source under North American Industry Classification System (NAICS) 811210 – Electronic and Precision Equipment Repair and Maintenance; with a Small Business Size Standard of $30 Million, and you believe that your firm would be able to provide the FDA with the service described below, please submit an email to suzanne.martella@fda.hhs.gov.
Other than small business concerns are also encouraged to submit capability statements. The vendor shall include information about the company and demonstrate that it can meet all of the minimum performance requirements.
The PM and unlimited repair service contract shall consist of a Base year plus four (4) possible one-year options. Each year shall be funded at the time the option year is exercised; options will be exercised based on funds availability and the needs of the Federal Government. The initial Service period shall be for one year and the subsequent periods of performance may be renewed at the government’s option for the period between 12-24 months, 24-36 months, 36-48 months and 48-60 months beyond the initial contract service period. Contractor quotes shall include details of the items covered under the service contract, any differing levels of the plan that are available, and the levels of service response that are available.
mailto:suzanne.martella@fda.hhs.gov
Minimum Performance Requirements for the Preventative Maintenance & Unlimited Repair Service Contract (Leica “Premium Care Service” or equal plan)
1. The Contractor shall provide one (1) scheduled on-site planned preventive maintenance visit per year which shall include all labor, travel, and OEM factory-certified replacement parts, components, subassemblies, etc., as well as consumables.
2. The Contractor shall provide unlimited on-site corrective maintenance/repairs for the entire SP8 confocal microscope system: Fluorescence lifetime (FLIM) system, Multi-photon modules with 4-channel dual detectors, Fluorescence Correlation Spectroscopy (FCS) and Fluorescence Cross- Correlation Spectroscopy (FCCS), tau Stimulated Emission Depletion (STED 3X) super-resolution microscopy and light sheet imaging system.
3. All maintenance/repair pricing shall be inclusive of labor, travel, replacement parts, components, subassemblies, etc. for the Leica SP8 STED confocal microscope system.
4. All maintenance and repair activities shall be performed by service technicians/engineers who are formally trained and certified by the original manufacturer. Engineers shall have access to the manufacturer’s latest technical developments, repair procedures, application updates, diagnostic software, and planned maintenance procedures. All repairs and PM services shall be performed following Original Equipment Manufacturer (OEM) specifications, manuals, and service bulletins, using OEM replacement parts, components, subassemblies, etc.
5. The contract shall enable the FDA Technical Point of Contact (TPOC) and system operator personnel to have unlimited direct access to the manufacturer’s call center for technical assistance, which is staffed by senior engineers to provide a high level of expertise for troubleshooting the equipment.
6. The contractor shall provide a two-hour telephone call back from Manufacturer’s Support Center and no more than a 24-hour response time after the initial call for a service response to equipment failure.
7. The Contractor shall include unlimited technical support Monday through Friday (excluding Federal Holidays) during contractor’s normal business hours.
8. Contract shall include priority onsite response time to ensure minimal instrumentation downtime.
9. Where issues cannot be resolved onsite, contractor shall be responsible for shipping the equipment to the OEM for repairs and shall provide loaner parts (within three days) to maintain operational capability of the instrument while equipment is being repaired or parts are on order.
10. Where problems cannot be resolved remotely, the contractor shall provide a preliminary plan of action for repairs within 48 hours of initial contact, followed by a mutually agreeable estimate for a planned on-site service call by a suitable technician capable of conducting repairs on the failed instrument(s). This mutually agreeable estimate should be provided within 72 hours of initial contact.
11. Service contract shall include unlimited free OEM system software, firmware and hardware support and updates that are needed for reliability improvements and correction of any defects.
Service Records and Reports: The Contractor shall, commensurate with the completion of each preventive maintenance service visit, provide the end-user of the equipment with a copy of a field service report/ticket identifying the equipment name, manufacturer, model number, and serial number of the equipment being serviced, a detailed description of the work performed, the test instruments or other equipment used to perform the service, the name(s) and contact information of the technician who performed the service, and for information purposes, the on-site hours expended, and parts/components replaced. In addition, the Contractor shall provide a written report to the FDA COR and Contract Specialist, summarizing all maintenance activities (including warranty work) each time service is performed.
Period(s) of Performance: Anticipated to be a Base plus four (4) Option Years with projected period of performance dates estimated as:
Base Year: 04/15/2023 – 04/14/2024 Option Year 1: 04/15/2024 – 04/14/2025 Option Year 2: 04/15/2025 – 04/14/2026 Option Year 3: 04/15/2026 – 04/14/2027 Option Year 4: 04/15/2027 – 04/14/2028
Place of Performance:
The equipment is located and shall be maintained at the Center for Biologics Research and Evaluation (CBER) at the following address:
US FDA/CBER
10903 New Hampshire Ave Silver Spring MD 20993
Responses to this Sources Sought shall unequivocally demonstrate that the respondent is regularly engaged in the sale of same or substantially similar service. Though the target audience is small business vendors or small businesses capable of supplying a U.S. product/service of a small business vendor or producer, all interested parties may respond. At a minimum, responses shall include the following:
• Business name and bio, Unique Entity ID (SAM) number, business address, business website, business size status (i.e., SB, VOSB, SDVOSB, HUBZone SB, SDB, WOSB, LB), point of contact name, mailing address (if different from business address), phone number and email address. Provide this same information again if responding to provide a service offered by another firm.
• Past Performance (within the last 3 years) information for the sale of same or substantially similar product/service to include date of sale, description, dollar value, client name, client address, client contact name, client point of contact mailing address (if different from that provided for client), client point of contact phone number, client point of contact email address, and name of the manufacturer (to include Unique Entity ID (SAM) number and size status) if not the respondent.
• Descriptive literature, brochures, marketing material, etc. detailing the nature of the service the responding firm is regularly engaged in manufacturing or selling.
• The offeror shall furnish sufficient technical information necessary for the Government to conclusively determine that the offered products/services meet the technical requirements identified above.
• The offeror’s estimated historical on-site response time for the brand name and model of instrument in this requirement.
• If applicable, identification of the firm’s GSA Schedule contract(s) by Schedule number and SINs that are applicable to this potential requirement are also requested.
• If applicable, identification of Best in Class (BIC) contract information or other Government-wide or HHS-wide contracts that the equipment/service is available on.
• If a large business, provide whether subcontracting opportunities exist for small business concerns.
• Standard commercial warranty and payment terms.
• Provide place of product manufacture or service performance and any other applicable information to enable review and analysis pertaining to the Buy American statute and requirements relating to Made in America in the event a nonavailability waiver request through the MIAO Digital Waiver Portal is needed.
• Though this is not a request for quote, informational pricing for the equipment/service would be helpful for market research purposes.
The Government is not responsible for locating or securing any information not identified in the response.
Interested Contractors must respond with capability statements which are to be submitted by email only to the point of contact listed below on or before 12:00pm (Central Time in Jefferson AR) on March 13, 2023 to Suzanne Martella, email suzanne.martella@fda.hhs.gov. Reference:
75F40123SSN116206.
Disclaimer and Important Notes
This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to mailto:suzanne.martella@fda.hhs.gov allow the Government to determine the organization’s qualifications to perform the work.
Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted.
After a review of the responses received, a pre‐solicitation synopsis or combined synopsis/ solicitation may be published in SAM.gov – Contracting Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation.
Confidentiality and Proprietary Information
No proprietary, classified, confidential, or sensitive information should be included in your response.
The Government reserves the right to use any non‐proprietary technical information in any resultant solicitation(s).
Additional Notes:
If the stated requirements appear restrictive, please submit comments detailing the concern. Though this is not a request for quote, informational pricing for the service would be helpful.
| THIS IS A SOURCES SOUGHT ANNOUNCEMENT, A MARKET SURVEY FOR WRITTEN INFORMATION ONLY. THIS IS NOT A SOLICITATION ANNOUNCEMENT FOR PROPOSALS AND NO CONTRACT WILL BE AWARDED FROM THIS ANNOUNCEMENT. NO REIMBURSEMENT WILL BE MADE FOR ANY COSTS ASSOCIATED W... |
| Place of Performance: |
| Disclaimer and Important Notes |
| Confidentiality and Proprietary Information |
File details come from the government source that posted it. Updated .